Coronary endothelial dysfunction in the hypertensive patient: From myocardial ischemia to heart failure

被引:18
作者
Burnett, JC
机构
[1] Cardiorenal Research Laboratory,Division of Cardiovascular Diseases
[2] Mayo Clinic and Foundation,undefined
关键词
endothelium; hormones; peptides;
D O I
10.1038/sj.jhh.1000400
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The endothelium modulates vascular tone by the release of vasodilator and vasoconstrictor substances, among them nitric oxide (NO) and endothelin (ET). Abnormalities in NO generation have been demonstrated in various cardiac pathophysiological states, specifically atherosclerotic vascular disease, congestive heart failure, and essential and pulmonary hypertension, Moreover, increases in plasma ET has been reported as well in these disease states, When these observations are taken together, these states may be characterized by an attenuated release of NO, whereas the release of ET is augmented, An imbalance between NO and ET may contribute to the alteration in vascular tone characteristic of cardiovascular disease, The following review summarizes the present knowledge of the role of NO and ET in such disease processes with a major focus on coronary endothelial dysfunction.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 28 条
[1]   ENDOTHELIN AT PATHOPHYSIOLOGICAL CONCENTRATIONS MEDIATES CORONARY VASOCONSTRICTION VIA THE ENDOTHELIN-A RECEPTOR [J].
CANNAN, CR ;
BURNETT, JC ;
BRANDT, RR ;
LERMAN, A .
CIRCULATION, 1995, 92 (11) :3312-3317
[2]  
CHAN DP, 1991, AM J HYPERTENS, V4, pA15
[3]   Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction [J].
Clavell, AL ;
Mattingly, MT ;
Stevens, TL ;
Nir, A ;
Wright, RS ;
Aarhus, LL ;
Heublein, DM ;
Burnett, JC .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (05) :1286-1292
[4]  
FLOREY HW, 1966, BRIT MED J, V2, P487
[5]   Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension [J].
Frielingsdorf, J ;
Seiler, C ;
Kaufmann, P ;
Vassalli, G ;
Suter, T ;
Hess, OM .
CIRCULATION, 1996, 93 (07) :1380-1387
[6]   THE OBLIGATORY ROLE OF ENDOTHELIAL-CELLS IN THE RELAXATION OF ARTERIAL SMOOTH-MUSCLE BY ACETYLCHOLINE [J].
FURCHGOTT, RF ;
ZAWADZKI, JV .
NATURE, 1980, 288 (5789) :373-376
[7]   ENDOTHELIN - A NEW CARDIOVASCULAR REGULATORY PEPTIDE [J].
LERMAN, A ;
HILDEBRAND, FL ;
MARGULIES, KB ;
OMURCHU, B ;
PERRELLA, MA ;
HEUBLEIN, DM ;
SCHWAB, TR ;
BURNETT, JC .
MAYO CLINIC PROCEEDINGS, 1990, 65 (11) :1441-1455
[8]   INHIBITION OF ENDOTHELIUM-DERIVED RELAXING FACTOR ENHANCES ENDOTHELIN-MEDIATED VASOCONSTRICTION [J].
LERMAN, A ;
SANDOK, EK ;
HILDEBRAND, FL ;
BURNETT, JC .
CIRCULATION, 1992, 85 (05) :1894-1898
[9]   ENDOTHELIN IN CORONARY ENDOTHELIAL DYSFUNCTION AND EARLY ATHEROSCLEROSIS IN HUMANS [J].
LERMAN, A ;
HOLMES, DR ;
BELL, MR ;
GARRATT, KN ;
NISHIMURA, RA ;
BURNETT, JC .
CIRCULATION, 1995, 92 (09) :2426-2431
[10]   CIRCULATING AND TISSUE ENDOTHELIN IMMUNOREACTIVITY IN ADVANCED ATHEROSCLEROSIS [J].
LERMAN, A ;
EDWARDS, BS ;
HALLETT, JW ;
HEUBLEIN, DM ;
SANDBERG, SM ;
BURNETT, JC .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (14) :997-1001